NASDAQ:FBIOP Fortress Biotech Q4 2022 Earnings Results & Report $15.48 +0.04 (+0.23%) As of 03:12 PM Eastern This is a fair market value price provided by Massive. Learn more. Fortress Biotech reported Q4 2022 earnings on March 30, 2023. The company reported EPS of -$0.11, while revenue was $16.40 million. Research:Profile Earnings Announcement Details QuarterQ4 2022Report DateMarch 30, 2023TimeAfter Market Closes Fortress Biotech EPS ResultsActual EPS-$0.11Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AFortress Biotech Revenue ResultsActual Revenue$16.40 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AUpcoming EarningsFortress Biotech's next earnings date is estimated for Monday, November 16, 2026, based on past reporting schedules. Conference Call ResourcesCompany Profile Fortress Biotech Q4 2022 Earnings FAQ Did Fortress Biotech beat earnings estimates for Q4 2022? Fortress Biotech (NASDAQ:FBIOP) reported earnings of -$0.11 per share for Q4 2022. The report was announced on Thursday, March 30, 2023. What was Fortress Biotech's revenue for Q4 2022? Fortress Biotech reported revenue of $16.40 million for Q4 2022. When is Fortress Biotech's next earnings date? Fortress Biotech's next earnings date is estimated for Monday, November 16, 2026. MarketBeat tracks confirmed and estimated earnings dates for Fortress Biotech on the company's earnings history page. Fortress Biotech Earnings HeadlinesFortress Biotech (FBIOP) Expected to Release Earnings on MondayNovember 9 at 4:27 AM | americanbankingnews.comFortress Biotech, Inc. - Preferred stock price target increased by 10.97% to $44.09October 23, 2026 | msn.comToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one lesser known company. With plans filed for 1,000,000 new satellites, that licensing fee could scale dramatically. Analyst Dylan says the stock could move by December 8th.November 10 at 1:00 AM | Behind the Markets (Ad)Fortress Biotech, Inc. - Preferred stock price target increased by 10.56% to $37.34September 15, 2026 | msn.comFortress Biotech to Present at the H.C. Wainwright 28th Annual Global Investment ConferenceSeptember 8, 2026 | globenewswire.comFortress Biotech Reports Second Quarter 2026 Financial Results and Recent Corporate HighlightsAugust 13, 2026 | globenewswire.comSee More Fortress Biotech Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Fortress Biotech? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Fortress Biotech and other key companies, straight to your email. Email Address About Fortress BiotechFortress Biotech (NASDAQ:FBIOP) is a U.S.-based biopharmaceutical company that acquires, develops and commercializes prescription medicines. Its work spans areas including oncology, rare diseases, dermatology and other specialty markets. The company operates through a network of subsidiary businesses and uses partnerships and licensing arrangements to advance drug candidates and bring therapies to market. Its portfolio includes both development-stage programs and commercial products, with activities conducted primarily in the United States. Fortress was founded in 2006 as Coronado Biosciences and adopted its current name in 2015. Founder Lindsay A. Rosenwald has served as the company’s chairman and chief executive officer.View Fortress Biotech ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles D-Wave Quantum Has Long-Term Potential, But Is Now the Time to Buy?Archer Aviation's FAA Certificate Is a Milestone, But It Isn't the Final OneDraftKings Just Lost 20%—And Its Biggest Gamble Is Still AheadBarrick's Earnings Beat Could Be Overshadowed by an Even Bigger OpportunityAxon vs. Motorola: Which Public Safety Stock Has More Upside After Q3 Earnings?Microsoft’s Neocloud Pullback Isn’t a Crack in AI DemandOklo Changes the Narrative: Does a Nuclear Stock Price Explosion Come Next? Upcoming Earnings Brookfield (11/12/2026)NU (11/12/2026)Applied Materials (11/12/2026)Cisco Systems (11/12/2026)Mizuho Financial Group (11/13/2026)Mitsubishi UFJ Financial Group (11/13/2026)Sumitomo Mitsui Financial Group (11/13/2026)Home Depot (11/17/2026)Walt Disney (11/17/2026)NVIDIA (11/17/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
